NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
James Dignam
University of Chicago - Chicago / United States
Others
AD Scientific Index ID: 1849942
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
James Dignam's MOST POPULAR ARTICLES
1-)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsEarly Breast Cancer Trialists\\\' Collaborative GroupThe Lancet 366 (9503), 2087-2106, 200555842005
2-)
A randomized trial of bevacizumab for newly diagnosed glioblastomaMR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...New England Journal of Medicine 370 (8), 699-708, 201425382014
3-)
Polychemotherapy for early breast cancer: an overview of the randomised trialsEarly Breast Cancer Trialists\\\' Collaborative GroupThe Lancet 352 (9132), 930-942, 199819501998
4-)
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialB Fisher, J Dignam, N Wolmark, DL Wickerham, ER Fisher, E Mamounas, ...The Lancet 353 (9169), 1993-2000, 199913481999
5-)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trialML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...The Lancet 393 (10166), 40-50, 201912012019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept